Oncology Therapeutics / NCI

Verified Pharmaceutical Manufacturer & Oncology Drug Supplier

Back to Pharmaceuticals Directory

Oncology Therapeutics / NCI

Verified Partner

Registered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.

Company Profile & Registration

Legal Organization NameOncology Therapeutics / NCI

Manufacturer Identification CodeRegistered

Authorized RepresentativeCorporate Representative

Compliance & StatusActive / Listed

Oncology Drugs & Clinical Formulations

Featured Drug Formulation

Cemiplimab-rwlc

Generic: Cemiplimab-rwlc

Class: Immune Checkpoint Inhibitor (PD-1 / PD-L1 / CTLA-4)

View Complete Drug Profile

Indications: Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.

Direct Communication & Assistance

Send an Inquiry to Oncology Therapeutics / NCI

Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.